RXO notice to sell 33,343 common shares via Morgan Stanley

Rhea-AI Filing Summary

RXO has a Form 144 notice for a proposed sale of 33,343 shares of common stock. The filing lists Morgan Stanley Smith Barney LLC as broker, with an approximate sale date of 11/10/2025 on the NYSE. The reported aggregate market value is $494,748.54.

The shares come from equity awards: performance shares acquired on 11/01/2022 (26,073 shares) and restricted stock acquired on 02/23/2024, 02/23/2025, and 03/22/2025 (totaling 7,270 shares). Shares outstanding were 164,111,872; this is a baseline figure, not the amount being sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	33343	494748.54	164111872	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/01/2022	Performance Shares	Issuer			26073	11/01/2022	Not Applicable
Common	02/23/2024	Restricted Stock	Issuer			3443	02/23/2024	Not Applicable
Common	02/23/2025	Restricted Stock	Issuer			2685	02/23/2025	Not Applicable
Common	03/22/2025	Restricted Stock	Issuer			1142	03/22/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many RXO (RXO) shares are proposed for sale in this Form 144?

33,343 shares of common stock are listed to be sold.

What aggregate market value is reported in the RXO Form 144?

The filing reports an aggregate market value of $494,748.54.

Who is the broker for the RXO Form 144 sale?

Morgan Stanley Smith Barney LLC is listed as the broker.

What is the approximate sale date in the RXO Form 144?

The approximate date of sale is 11/10/2025.

On which exchange will the RXO shares be sold?

The filing names the NYSE as the exchange.

What are the sources of the RXO shares to be sold?

The shares derive from performance shares acquired on 11/01/2022 (26,073) and restricted stock acquired on 02/23/2024, 02/23/2025, and 03/22/2025 (7,270 total).

How many RXO shares are outstanding per the filing?

The filing shows 164,111,872 shares outstanding.